Earnings Call · Q4 FY2023·2023-12-14

Q4 23EPS +23.53%·Rev n/aQ3 23EPS +2.44%·Rev n/aQ2 23EPS -2.44%·Rev n/aQ1 23EPS 0.00%·Rev n/a⚠ consensus missing

NEUROONE MEDICAL TECHNOLOGIES Corp NMTC

Dave Rosa — Chief Executive Officer

Ron McClurg — Chief Financial Officer

−11.0%1d on move date−10.9% vs SPY3d−18.6%5d−19.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NMTC calls or request research access.

More NMTC calls Browse calls Request research access